Ingo V. Hartung - Concepedia

Author

Ingo V. Hartung

Also Known As

Hartung, Ingo V., I Hartung, I.V. Hartung, Ingo Hartung, Ingo V Hartung, Ingo V. Hartung, Ingo Volker Hartung, Matyas Gorjanacz

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Bayer (Germany)Merck (Germany)Leibniz University Hannover Heidelberg University German Cancer Research Center

About

Ingo V. Hartung is an author at Bayer (Germany) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	353
2	Natural Sciences	7	7	340
3	Biochemistry	6	6	324
4	Chemical Biology	4	4	236
5	Engineering	1	1	14

Ingo V. Hartung

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
8‐Oxabicyclo[3.2.1]oct‐6‐en‐3‐ones: Application to the Asymmetric Synthesis of Polyoxygenated Building Blocks Ingo V. Hartung, H. M. R. Hoffmann Angewandte Chemie International Edition	2004	146
Electronic and Steric Control of Regioselectivities in Rh(I)-Catalyzed (5 + 2) Cycloadditions: Experiment and Theory Peng Liu, Lauren E. Sirois, Paul Ha‐Yeon Cheong, Journal of the American Chemical Society	2010	136
Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action Amaury E. Fernández‐Montalván, Markus Berger, Benno Kuropka, ACS Chemical Biology Atad2 Bromodomain DimerizationEpigenetic ChangeGeneticsNovel Chemical StructureGenomic Mechanism	2017	88
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2 Erik Eggert, R.C. Hillig, Silke Koehr, Journal of Medicinal Chemistry Histone ModificationsDrug TargetEpigenetic ChangeMolecular BiologyProtein Methylation	2016	86
Discovery of Molidustat (BAY 85‐3934): A Small‐Molecule Oral HIF‐Prolyl Hydroxylase (HIF‐PH) Inhibitor for the Treatment of Renal Anemia Hartmut Beck, Mario Jeske, Kai Thede, ChemMedChem Bay 85‐3934Hif-ph Mimics HypoxiaPharmacotherapyPharmaceutical ChemistryMolecular Pharmacology	2018	74
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains Léa Bouché, Clara D. Christ, Stephan Siegel, Journal of Medicinal Chemistry	2017	66
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy Christina Kober, Julian Roewe, Norbert Schmees, Journal for ImmunoTherapy of Cancer	2023	64
Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design Johannes Krieger, F.J. Sorrell, Ansgar Wegener, ChemMedChem Combinatorial ChemistryOrganic ChemistryChemical BiologyPharmaceutical ChemistryInorganic Compound	2023	48
The Total Syntheses of Phorboxazoles—New Classics in Natural Product Synthesis Lars Ole Haustedt, Ingo V. Hartung, H. M. R. Hoffmann Angewandte Chemie International Edition	2003	42
Identifying palladium culprits in amine catalysis Mickaël Avanthay, Robin B. Bedford, Callum S. Begg, Nature Catalysis Palladium CulpritsOrganometallic CatalysisCatalysisMolecular CatalysisChemistry	2021	40

Page 1